Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00208546
Status:
COMPLETED
Last Update Posted:
2012-02-02
First Post:
2005-09-13
Brief Title:
Cetuximab Capecitabine Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer
Sponsor:
Dutch Colorectal Cancer Group
Organization:
Dutch Colorectal Cancer Group
Organization Data
Organization:
Dutch Colorectal Cancer Group
Class:
OTHER
Study ID:
CAIRO2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dutch Colorectal Cancer Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Koningin Wilhelmina Fonds | OTHER |
| Sanofi | INDUSTRY |
| Roche Pharma AG | INDUSTRY |
| Immunicon | INDUSTRY |